Literature DB >> 15174846

The structure and conformational behavior of sulfonium salt glycosidase inhibitors in solution: a combined quantum mechanical NMR approach.

Jorge Gonzalez-Outeiriño1, John Glushka, Aloysius Siriwardena, Robert J Woods.   

Abstract

We present the conformational analysis of an inhibitor of alpha-mannosidase, based on a novel sulfonium salt structure (1) that mimics the mannosyl cation intermediate. Because of the number of possible isomeric structures for 1, as well as its complex molecular structure, traditional conformational analysis by NMR was not applicable. Instead, a single experimentally consistent structure was obtained from finite perturbation quantum mechanical calculations of the NMR J-couplings at the B3LYP/6-311G** level. Using a full relaxation matrix analysis, we showed that the quantum-predicted NMR structure was the only isomer that was consistent with the experimental NOE intensities. The results illustrate the potential for finite perturbation calculations to be useful in the analysis of complex charged molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174846      PMCID: PMC1386731          DOI: 10.1021/ja049700k

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  9 in total

Review 1.  Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin.

Authors:  Vinni H Lillelund; Henrik H Jensen; Xifu Liang; Mikael Bols
Journal:  Chem Rev       Date:  2002-02       Impact factor: 60.622

2.  Analysis of NMR J couplings in partially protected galactopyranosides.

Authors:  E Andreas Larsson; Jozef Ulicny; Aatto Laaksonen; Göran Widmalm
Journal:  Org Lett       Date:  2002-05-30       Impact factor: 6.005

3.  Antidiabetic principles of natural medicines. IV. Aldose reductase and qlpha-glucosidase inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): structure of a new friedelane-type triterpene, kotalagenin 16-acetate.

Authors:  H Matsuda; T Murakami; K Yashiro; J Yamahara; M Yoshikawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-12       Impact factor: 1.645

4.  Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata.

Authors:  M Yoshikawa; T Murakami; K Yashiro; H Matsuda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1998-08       Impact factor: 1.645

5.  Identification of the active site nucleophile in jack bean alpha-mannosidase using 5-fluoro-beta-L-gulosyl fluoride.

Authors:  S Howard; S He; S G Withers
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

6.  Hydroxymethyl group conformation in saccharides: structural dependencies of (2)J(HH), (3)J(HH), and (1)J(CH) spin-spin coupling constants.

Authors:  Roland Stenutz; Ian Carmichael; Göran Widmalm; Anthony S Serianni
Journal:  J Org Chem       Date:  2002-02-08       Impact factor: 4.354

7.  A new class of glycosidase inhibitor: synthesis of salacinol and its stereoisomers.

Authors:  A Ghavami; B D Johnston; B M Pinto
Journal:  J Org Chem       Date:  2001-04-06       Impact factor: 4.354

8.  Insights into the mechanism of Drosophila melanogaster Golgi alpha-mannosidase II through the structural analysis of covalent reaction intermediates.

Authors:  Shin Numao; Douglas A Kuntz; Stephen G Withers; David R Rose
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

9.  Studies of an immunomodulator, swainsonine. I. Enhancement of immune response by swainsonine in vitro.

Authors:  M Hino; O Nakayama; Y Tsurumi; K Adachi; T Shibata; H Terano; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1985-07       Impact factor: 2.649

  9 in total
  1 in total

1.  Reconciling solvent effects on rotamer populations in carbohydrates - A joint MD and NMR analysis.

Authors:  Jorge Gonzalez-Outeiriño; Karl N Kirschner; Smita Thobhani; Robert J Woods
Journal:  Can J Chem       Date:  2006-04-01       Impact factor: 1.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.